These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28694399)

  • 1. Familial hypertrophic cardiomyopathy: A case with a new mutation in the MYBPC3 gene.
    Hallıoğlu Kılınç O; Giray D; Bişgin A; Tuğ Bozdoğan S; Karpuz D
    Turk Kardiyol Dern Ars; 2017 Jul; 45(5):450-453. PubMed ID: 28694399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of a large duplication mutation in the myosin-binding protein C3 gene in a case of hypertrophic cardiomyopathy.
    Meyer T; Pankuweit S; Richter A; Maisch B; Ruppert V
    Gene; 2013 Sep; 527(1):416-20. PubMed ID: 23816408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compound heterozygous or homozygous truncating MYBPC3 mutations cause lethal cardiomyopathy with features of noncompaction and septal defects.
    Wessels MW; Herkert JC; Frohn-Mulder IM; Dalinghaus M; van den Wijngaard A; de Krijger RR; Michels M; de Coo IF; Hoedemaekers YM; Dooijes D
    Eur J Hum Genet; 2015 Jul; 23(7):922-8. PubMed ID: 25335496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse events in families with hypertrophic or dilated cardiomyopathy and mutations in the MYBPC3 gene.
    Ehlermann P; Weichenhan D; Zehelein J; Steen H; Pribe R; Zeller R; Lehrke S; Zugck C; Ivandic BT; Katus HA
    BMC Med Genet; 2008 Oct; 9():95. PubMed ID: 18957093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in the cardiac myosin-binding protein C gene are the predominant cause of familial hypertrophic cardiomyopathy in eastern Finland.
    Jääskeläinen P; Kuusisto J; Miettinen R; Kärkkäinen P; Kärkkäinen S; Heikkinen S; Peltola P; Pihlajamäki J; Vauhkonen I; Laakso M
    J Mol Med (Berl); 2002 Jul; 80(7):412-22. PubMed ID: 12110947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into genotype-phenotype correlation in hypertrophic cardiomyopathy. Findings from 18 Spanish families with a single mutation in MYBPC3.
    Oliva-Sandoval MJ; Ruiz-Espejo F; Monserrat L; Hermida-Prieto M; Sabater M; García-Molina E; Ortiz M; Rodríguez-García MI; Núñez L; Gimeno JR; Castro-Beiras A; Valdés M
    Heart; 2010 Dec; 96(24):1980-4. PubMed ID: 21088121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fast diastolic swinging motion of the mitral valve as a clinical marker of familial hypertrophic cardiomyopathy in genetically affected young children without left ventricular hypertrophy: a new role for noninvasive imaging?
    Udink ten Cate FE; Junghaenel S; Brockmeier K; Sreeram N
    Echocardiography; 2013 Aug; 30(7):E185-7. PubMed ID: 23557229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Echocardiographic study of double mutations of myosin-binding protein C3 gene in Chinese patients with familial hypertrophic cardiomyopathy].
    Zhao B; Li J; Yang F; Zhi G
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Jan; 38(1):14-9. PubMed ID: 23406853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of familial hypertrophic cardiomyopathy emphasizes the importance of parallel screening of multiple disease genes.
    Scheffold T; Waldmüller S; Borisov K
    Clin Res Cardiol; 2011 Jul; 100(7):627-8. PubMed ID: 21409595
    [No Abstract]   [Full Text] [Related]  

  • 10. MYBPC3 hypertrophic cardiomyopathy can be detected by using advanced ECG in children and young adults.
    Fernlund E; Liuba P; Carlson J; Platonov PG; Schlegel TT
    J Electrocardiol; 2016; 49(3):392-400. PubMed ID: 27061026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertrophic cardiomyopathy without hypertrophy: an emerging pre-clinical subgroup composed of genetically affected family members.
    Maron BJ; Ho CY
    JACC Cardiovasc Imaging; 2009 Jan; 2(1):65-8. PubMed ID: 19356535
    [No Abstract]   [Full Text] [Related]  

  • 12. A Novel Founder Mutation in MYBPC3: Phenotypic Comparison With the Most Prevalent MYBPC3 Mutation in Spain.
    Sabater-Molina M; Saura D; García-Molina Sáez E; González-Carrillo J; Polo L; Pérez-Sánchez I; Olmo MDC; Oliva-Sandoval MJ; Barriales-Villa R; Carbonell P; Pascual-Figal D; Gimeno JR
    Rev Esp Cardiol (Engl Ed); 2017 Feb; 70(2):105-114. PubMed ID: 28029522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diastolic abnormalities as the first feature of hypertrophic cardiomyopathy in Dutch myosin-binding protein C founder mutations.
    Michels M; Soliman OI; Kofflard MJ; Hoedemaekers YM; Dooijes D; Majoor-Krakauer D; ten Cate FJ
    JACC Cardiovasc Imaging; 2009 Jan; 2(1):58-64. PubMed ID: 19356534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights Into Hypertrophic Cardiomyopathy Evaluation Through Follow-up of a Founder Pathogenic Variant.
    Lorca R; Gómez J; Martín M; Cabanillas R; Calvo J; León V; Pascual I; Morís C; Coto E; R Reguero JJ
    Rev Esp Cardiol (Engl Ed); 2019 Feb; 72(2):138-144. PubMed ID: 29631964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MYBPC3 polymorphism is a modifier for expression of cardiac hypertrophy in patients with hypertrophic cardiomyopathy.
    Wang P; Zou Y; Fu C; Zhou X; Hui R
    Biochem Biophys Res Commun; 2005 Apr; 329(2):796-9. PubMed ID: 15737656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variable clinical manifestation of a novel missense mutation in the alpha-tropomyosin (TPM1) gene in familial hypertrophic cardiomyopathy.
    Jongbloed RJ; Marcelis CL; Doevendans PA; Schmeitz-Mulkens JM; Van Dockum WG; Geraedts JP; Smeets HJ
    J Am Coll Cardiol; 2003 Mar; 41(6):981-6. PubMed ID: 12651045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene symbol: MYBPC3. Disease: Hypertrophic cardiomyopathy.
    Golubenko MV; Puzyrev KV; Puzyrev VP; Pavlukova EN; Makeeva OA; Vosberg HP
    Hum Genet; 2004 Mar; 114(4):406. PubMed ID: 15046084
    [No Abstract]   [Full Text] [Related]  

  • 18. Burden of Recurrent and Ancestral Mutations in Families With Hypertrophic Cardiomyopathy.
    Ross SB; Bagnall RD; Ingles J; Van Tintelen JP; Semsarian C
    Circ Cardiovasc Genet; 2017 Jun; 10(3):. PubMed ID: 28615295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic Diversity of Cardiomyopathy Caused by an
    Park J; Lee JM; Cho JS
    Medicina (Kaunas); 2021 Mar; 57(3):. PubMed ID: 33803538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Returning hypertrophy after surgery in a patient with hypertrophic cardiomyopathy caused by a myosin-binding protein C mutation.
    Kabaeva Z; Perrot A; Pilz B; Schulz-Menger J; Mohr FW; Dietz R; Osterziel KJ
    Int J Cardiol; 2005 Apr; 100(2):343-5. PubMed ID: 15823648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.